{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:02Z","timestamp":1793158142373,"version":"4.5.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["24KFL091"],"award-info":[{"award-number":["24KFL091"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305313"],"award-info":[{"award-number":["82305313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.autrev.2026.104098","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:18:11Z","timestamp":1779725891000},"page":"104098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Jun","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10432","key":"10.1016\/j.autrev.2026.104098_bb0005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"issue":"10401","key":"10.1016\/j.autrev.2026.104098_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2024.02.026","article-title":"Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease","volume":"167","author":"Khrom","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0025","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","article-title":"Comparative risk of serious infections with biologic agents and oral small molecules in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"21","author":"Solitano","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf052","article-title":"Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study","volume":"19","author":"Bokemeyer","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2026.104098_bb0040","first-page":"359","article-title":"Management of inflammatory bowel disease in poor responders to infliximab","volume":"7","author":"Guerra","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104098_bb0045","article-title":"Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study","volume":"47","author":"Sarter","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.autrev.2026.104098_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01847","article-title":"Biological therapy in Inflammatory Bowel Disease patients partly restores intestinal innate lymphoid cell subtype equilibrium","volume":"11","author":"Creyns","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf006","article-title":"Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease","volume":"19","author":"Wong","year":"2025","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104098_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124441","article-title":"Innate immune cells and their contribution to T-Cell-based immunotherapy","volume":"21","author":"Ginefra","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn\u2019s Disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41385-020-00368-1","article-title":"The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes","volume":"14","author":"Jacobson","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice","volume":"14","author":"Gisbert","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"Supplement_2","key":"10.1016\/j.autrev.2026.104098_bb0095","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1093\/ecco-jcc\/jjac007","article-title":"IL-23 blockade in Anti-TNF refractory IBD: from mechanisms to clinical reality","volume":"16","author":"Atreya","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.autrev.2026.104098_bb0105","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.devcel.2024.06.010","article-title":"Human yolk sac-derived innate lymphoid-biased multipotent progenitors emerge prior to hematopoietic stem cell formation","volume":"59","author":"Ni","year":"2024","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2024.12.012","article-title":"Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow","volume":"58","author":"Robles-Vera","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104098_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2025.104957","article-title":"Potential therapeutic strategies targeting efferocytosis for inflammation resolution and tissue repair in inflammatory bowel disease","volume":"411-412","author":"Li","year":"2025","journal-title":"Cell Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1540-2","article-title":"ILC3 function as a double-edged sword in inflammatory bowel diseases","volume":"10","author":"Zeng","year":"2019","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012394","article-title":"Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages","volume":"20","author":"Long","year":"2024","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0130","article-title":"The relationship between CSF1R signaling, monocyte-macrophage differentiation, and susceptibility to inflammatory bowel disease","volume":"19","author":"Hume","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104098_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662063","article-title":"Microbial phagocytic receptors and their potential involvement in cytokine induction in macrophages","volume":"12","author":"Fu","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.873","article-title":"Human dendritic cell enrichment and their activation of T cells","volume":"3","author":"Lubin","year":"2023","journal-title":"Curr Protoc"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0145","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.immuni.2023.07.001","article-title":"Dendritic cell type 3 arises from Ly6C(+) monocyte-dendritic cell progenitors","volume":"56","author":"Liu","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2009.06.025","article-title":"Intestinal lamina propria dendritic cell subsets have different origin and functions","volume":"31","author":"Varol","year":"2009","journal-title":"Immunity"},{"issue":"30","key":"10.1016\/j.autrev.2026.104098_bb0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.autrev.2026.104098_bb0160","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.1004036","article-title":"A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity","volume":"186","author":"Fujimoto","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.0105-2896.2009.00874.x","article-title":"Development and functional specialization of CD103+ dendritic cells","volume":"234","author":"del Rio","year":"2010","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.it.2011.10.001","article-title":"How vitamin A metabolizing dendritic cells are generated in the gut mucosa","volume":"33","author":"Agace","year":"2012","journal-title":"Trends Immunol"},{"issue":"15","key":"10.1016\/j.autrev.2026.104098_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158200","article-title":"Moderate aerobic exercise induces homeostatic IgA generation in senile mice","volume":"25","author":"Hern\u00e1ndez-Urb\u00e1n","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.autrev.2026.104098_bb0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/intimm\/dxab049","article-title":"Reciprocal regulation of IgA and the gut microbiota: a key mutualism in the intestine","volume":"33","author":"Takeuchi","year":"2021","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/imr.13163","article-title":"Microbes and the fate of neutrophils","volume":"314","author":"Kobayashi","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2026.104098_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111950","article-title":"Neutrophils display distinct post-translational modifications in response to varied pathological stimuli","volume":"132","author":"Thimmappa","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72750-9","article-title":"Cell type specific gene expression profiling reveals a role for complement component C3 in neutrophil responses to tissue damage","volume":"10","author":"Houseright","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05539-3","article-title":"Dual role of CD177+neutrophils in inflammatory bowel disease: a review","volume":"22","author":"Zheng","year":"2024","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0205","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2016-313535","article-title":"CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104098_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650864","article-title":"Triggering receptor expressed on myeloid cells-1 agonist regulates intestinal inflammation via Cd177(+) neutrophils","volume":"12","author":"Seo","year":"2021","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.autrev.2026.104098_bb0215","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2012-04-421040","article-title":"VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue","volume":"120","author":"Christoffersson","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10409238.2016.1199535","article-title":"The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases","volume":"51","author":"de Bruyn","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0225","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109386","article-title":"Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs","volume":"41","author":"Lentini","year":"2022","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0230","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mi.2016.80","article-title":"IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria","volume":"10","author":"Flannigan","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0235","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ibd\/izac199","article-title":"The pathogenicity and synergistic action of Th1 and Th17 cells in inflammatory bowel diseases","volume":"29","author":"Cao","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0240","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from IBD to the gut microbiota","volume":"21","author":"Danne","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.immuni.2014.12.028","article-title":"Antimicrobial defense of the intestine","volume":"42","author":"Mukherjee","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0255","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","article-title":"Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine","volume":"5","author":"Raffatellu","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chom.2013.06.007","article-title":"Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron","volume":"14","author":"Deriu","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijmm.2009.08.008","article-title":"The role of innate signaling in the homeostasis of tolerance and immunity in the intestine","volume":"300","author":"Wells","year":"2010","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","article-title":"Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD","volume":"16","author":"Na","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-024-00612-x","article-title":"Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease","volume":"12","author":"Lu","year":"2024","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12964-023-01386-9","article-title":"Macrophage polarization in inflammatory bowel disease","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0285","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41385-018-0030-7","article-title":"Human intestinal pro-inflammatory CD11c(high)CCR2(+)CX3CR1(+) macrophages, but not their tolerogenic CD11c(\u2212)CCR2(\u2212) CX3CR1(\u2212) counterparts, are expanded in inflammatory bowel disease","volume":"11","author":"Bernardo","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111191","article-title":"Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development","volume":"40","author":"Pinget","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0295","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"67","author":"Palmela","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0300","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.07.048","article-title":"Self-maintaining gut macrophages are essential for intestinal homeostasis","volume":"175","author":"De Schepper","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0305","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/00365521.2015.1134649","article-title":"Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-\u03b1 treatment in patients with Crohn\u2019s disease","volume":"51","author":"Dige","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"41","key":"10.1016\/j.autrev.2026.104098_bb0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407130121","article-title":"SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor","volume":"121","author":"Alnouri","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0315","doi-asserted-by":"crossref","first-page":"G169","DOI":"10.1152\/ajpgi.00194.2021","article-title":"Cells and mediators of inflammation as effectors of epithelial repair in the inflamed intestine","volume":"322","author":"Crifo","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.13278","article-title":"Specialized pro-resolving mediators enhance the clearance of dead cells","volume":"319","author":"Fredman","year":"2023","journal-title":"Immunol Rev"},{"issue":"7261","key":"10.1016\/j.autrev.2026.104098_bb0325","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104098_bb0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fimmu.2018.00127","article-title":"Macrophage clearance of apoptotic cells: a critical assessment","volume":"9","author":"Gordon","year":"2018","journal-title":"Front Immunol"},{"issue":"7630","key":"10.1016\/j.autrev.2026.104098_bb0335","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nature20138","article-title":"Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs","volume":"539","author":"Cummings","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0340","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2478\/jtim-2023-0123","article-title":"Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease","volume":"11","author":"Zhang","year":"2023","journal-title":"J Transl Int Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2024.08.012","article-title":"Thiamine-reduced fatigue in quiescent inflammatory bowel disease is linked to Faecalibacterium prausnitzii abundance","volume":"4","author":"Berm\u00fadez-S\u00e1nchez","year":"2025","journal-title":"Gastro Hep Adv"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0350","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2517380","article-title":"Human gut commensal Alistipes timonensis modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an Il10-deficient mouse model","volume":"17","author":"Older","year":"2025","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22212-1","article-title":"Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon","volume":"12","author":"Nakamura","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104098_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115276","article-title":"The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials","volume":"165","author":"Duan","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.autrev.2026.104098_bb0365","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.cmet.2021.10.010","article-title":"Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease","volume":"33","author":"Erny","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2026.104098_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101291","article-title":"Immunology of bile acids regulated receptors","volume":"95","author":"Fiorucci","year":"2024","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.autrev.2026.104098_bb0375","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/ncomms2957","article-title":"Persistent infection with Crohn\u2019s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis","volume":"4","author":"Small","year":"2013","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.autrev.2026.104098_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00587-19","article-title":"Yersiniabactin-producing adherent\/invasive Escherichia coli promotes inflammation-associated fibrosis in gnotobiotic Il10(\u2212\/\u2212) mice","volume":"87","author":"Ellermann","year":"2019","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0385","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/gutjnl-2015-310382","article-title":"Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn\u2019s disease","volume":"66","author":"Schwerd","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0390","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chom.2024.11.012","article-title":"Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn\u2019s disease","volume":"33","author":"Ahn","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0395","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1128\/IAI.69.9.5529-5537.2001","article-title":"Adherent invasive Escherichia coli strains from patients with Crohn\u2019s disease survive and replicate within macrophages without inducing host cell death","volume":"69","author":"Glasser","year":"2001","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2026.104098_bb0400","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1078\/1438-4221-00201","article-title":"Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn\u2019s disease","volume":"292","author":"Darfeuille-Michaud","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0405","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2193115","article-title":"Crohn\u2019s disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2026.104098_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107688","article-title":"Costunolide ameliorates colitis via specific inhibition of HIF1\u03b1\/glycolysis-mediated Th17 differentiation","volume":"97","author":"Lv","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s42003-021-02161-7","article-title":"The Crohn\u2019s disease-related bacterial strain LF82 assembles biofilm-like communities to protect itself from phagolysosomal attack","volume":"4","author":"Prudent","year":"2021","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112471","article-title":"The glycolysis\/HIF-1\u03b1 axis defines the inflammatory role of IL-4-primed macrophages","volume":"42","author":"Dang","year":"2023","journal-title":"Cell Rep"},{"issue":"17","key":"10.1016\/j.autrev.2026.104098_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179422","article-title":"Macrophages and gut barrier function: guardians of gastrointestinal health in post-inflammatory and post-infection responses","volume":"25","author":"Meng","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0430","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0435","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154993","article-title":"Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage","volume":"132","author":"Rusu","year":"2022","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0440","doi-asserted-by":"crossref","first-page":"G123","DOI":"10.1152\/ajpgi.00316.2016","article-title":"miR-200b inhibits TNF-\u03b1-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro","volume":"312","author":"Shen","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104098_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04151-3","article-title":"TNF-\u03b1 synergises with IFN-\u03b3 to induce caspase-8-JAK1\/2-STAT1-dependent death of intestinal epithelial cells","volume":"12","author":"Woznicki","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0450","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cbin.11935","article-title":"Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP\/NLRP3 pathway in rats","volume":"47","author":"Yu","year":"2023","journal-title":"Cell Biol Int"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0455","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41584-023-01002-7","article-title":"TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond","volume":"19","author":"Siegmund","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0460","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","article-title":"Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease","volume":"180","author":"Lee","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0470","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"IL-12 and IL-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010173","article-title":"Gram-positive bacteria cell wall peptidoglycan polymers activate human dendritic cells to produce IL-23 and IL-1\u03b2 and promote T(H)17 cell differentiation","volume":"11","author":"Turner","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0480","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/gutjnl-2019-318264","article-title":"Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling","volume":"69","author":"Koelink","year":"2020","journal-title":"Gut"},{"issue":"8016","key":"10.1016\/j.autrev.2026.104098_bb0485","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-07501-1","article-title":"A disease-associated gene desert directs macrophage inflammation through ETS2","volume":"630","author":"Stankey","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MIB.0b013e3182a69dca","article-title":"The role of macrophages and dendritic cells in the initiation of inflammation in IBD","volume":"20","author":"Steinbach","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0495","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/ibd\/izaf017","article-title":"Single-cell transcriptomic profile of innate cell populations in mesenteric lymph nodes of inflammatory bowel disease patients","volume":"31","author":"Wils","year":"2025","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0500","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/mi.2015.48","article-title":"Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation","volume":"9","author":"Magnusson","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0505","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri.2016.116","article-title":"Dendritic cell migration in health and disease","volume":"17","author":"Worbs","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0510","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/15548627.2021.1909406","article-title":"How autophagy controls the intestinal epithelial barrier","volume":"18","author":"Foerster","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0515","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4049\/jimmunol.176.2.803","article-title":"CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes","volume":"176","author":"Jang","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104098_bb0520","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4161\/hv.26065","article-title":"The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting","volume":"9","author":"Atanackovic","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"32","key":"10.1016\/j.autrev.2026.104098_bb0525","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400153121","article-title":"An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation","volume":"121","author":"Alakhras","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0530","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1189\/jlb.3VMA1015-476R","article-title":"Retinoic acid-primed human dendritic cells inhibit Th9 cells and induce Th1\/Th17 cell differentiation","volume":"100","author":"Rampal","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0535","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ibd\/izaa121","article-title":"Retinoic acid is elevated in the mucosa of patients with active ulcerative colitis and displays a proinflammatory role by augmenting IL-17 and IFN\u03b3 production","volume":"27","author":"Rampal","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0540","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjz194","article-title":"Enteroids derived from inflammatory bowel disease patients display dysregulated endoplasmic reticulum stress pathways, leading to differential inflammatory responses and dendritic cell maturation","volume":"14","author":"Rees","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0545","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41423-024-01158-6","article-title":"Neutrophil-derived PAD4 induces citrullination of CKMT1 exacerbates mucosal inflammation in inflammatory bowel disease","volume":"21","author":"Wang","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0550","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gutjnl-2022-326917","article-title":"CARD9 in neutrophils protects from colitis and controls mitochondrial metabolism and cell survival","volume":"72","author":"Danne","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0555","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43573-9","article-title":"Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts","volume":"14","author":"Hackert","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0560","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1053\/j.gastro.2018.02.016","article-title":"Clinical and genomic correlates of neutrophil reactive oxygen species production in pediatric patients with Crohn\u2019s disease","volume":"154","author":"Denson","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0565","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jcmgh.2022.09.002","article-title":"Neutrophil-epithelial crosstalk during intestinal inflammation","volume":"14","author":"Kang","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104098_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198952","article-title":"Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy","volume":"14","author":"Yao","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.smim.2016.04.003","article-title":"Neutrophil-derived chemokines on the road to immunity","volume":"28","author":"Tecchio","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2026.104098_bb0580","first-page":"1","article-title":"Neutrophil-derived serine proteases induce FOXA2-mediated autophagy dysfunction and exacerbate colitis-associated carcinogenesis via protease activated receptor 2","author":"Yuan","year":"2025","journal-title":"Autophagy"},{"issue":"6120","key":"10.1016\/j.autrev.2026.104098_bb0585","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1232467","article-title":"Host-derived nitrate boosts growth of E. coli in the inflamed gut","volume":"339","author":"Winter","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0590","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.01.017","article-title":"Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut","volume":"11","author":"Liu","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.autrev.2026.104098_bb0595","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180984","article-title":"Advancing chemokine research: the molecular function of CXCL8","volume":"134","author":"Hou","year":"2024","journal-title":"J Clin Invest"},{"issue":"45","key":"10.1016\/j.autrev.2026.104098_bb0600","doi-asserted-by":"crossref","first-page":"74247","DOI":"10.18632\/oncotarget.12093","article-title":"Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0605","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12967-024-05058-1","article-title":"Predictive biomarkers for anti-TNF alpha therapy in IBD patients","volume":"22","author":"Kumar","year":"2024","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104098_bb0610","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11894-021-00829-y","article-title":"Immunomodulatory agents for treatment of patients with inflammatory bowel disease (review safety of anti-TNF, anti-integrin, anti IL-12\/23, JAK inhibition, sphingosine 1-phosphate receptor modulator, azathioprine \/ 6-MP and methotrexate)","volume":"23","author":"Sattler","year":"2021","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0615","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/14712598.2024.2316180","article-title":"Clinical use of biologics for Crohn\u2019s disease in adults: lessons learned from real-world studies","volume":"24","author":"Tursi","year":"2024","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0620","first-page":"1122","article-title":"TNF-anti-TNF immune complexes inhibit IL-12\/IL-23 secretion by inflammatory macrophages via an Fc-dependent mechanism","volume":"12","author":"Bloemendaal","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0625","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf026","article-title":"Anti-tumor necrosis factor therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells","volume":"117","author":"Wang","year":"2025","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2026.104098_bb0630","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3021863","article-title":"Anti-TNF-\u03b1 therapy suppresses proinflammatory activities of mucosal neutrophils in inflammatory bowel disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Mediat Inflamm"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0635","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/iub.2807","article-title":"Screening and experimental validation of diagnostic gene in ulcerative colitis with anti-TNF-\u03b1 therapy","volume":"76","author":"Chen","year":"2024","journal-title":"IUBMB Life"},{"issue":"10","key":"10.1016\/j.autrev.2026.104098_bb0640","doi-asserted-by":"crossref","first-page":"772","DOI":"10.20452\/pamw.3550","article-title":"Update on the mechanisms of action of anti-TNF-\u03b1 antibodies and their clinical implications in inflammatory bowel disease","volume":"126","author":"Eder","year":"2016","journal-title":"Pol Arch Med Wewn"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0645","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ibd\/izac246","article-title":"The clinical response of upadacitinib and risankizumab is associated with reduced inflammatory bowel disease anti-TNF-\u03b1 inadequate response mechanisms","volume":"29","author":"Wang","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081885","article-title":"Differential effects of anti-TNF\u03b1 and anti-\u03b14\u03b27 drugs on circulating dendritic cells migratory capacity in inflammatory bowel disease","volume":"10","author":"Soleto","year":"2022","journal-title":"Biomedicines"},{"issue":"Supplement_2","key":"10.1016\/j.autrev.2026.104098_bb0655","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention","volume":"16","author":"Sewell","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0660","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/gutjnl-2018-316830","article-title":"IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes","volume":"69","author":"Sun","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104098_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117399","article-title":"Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12\/JAK2\/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer","volume":"320","author":"Kong","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104098_bb0670","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/thno.96184","article-title":"Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis","volume":"14","author":"Cai","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0675","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","volume":"68","author":"Zeissig","year":"2019","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0680","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cgh.2022.08.024","article-title":"Complete endoscopic healing is associated with lower relapse risk after anti-TNF withdrawal in inflammatory bowel disease","volume":"21","author":"Mahmoud","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0685","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10620-024-08816-9","article-title":"Retrospective cohort study on the predictive value of primary non-response to initial biologic for future biologic use in patients with inflammatory bowel disease","volume":"70","author":"Krishna","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0690","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.gastrohep.2022.10.021","article-title":"Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors","volume":"46","author":"Davis Gonz\u00e1lez","year":"2023","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0695","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ecco-jcc\/jjac164","article-title":"A systematic review on the interest of drug-tolerant assay in the monitoring of inflammatory bowel disease","volume":"17","author":"Barrau","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2026.104098_bb0700","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211037849","article-title":"Dynamics of serum concentrations of antibodies to infliximab: a new approach for predicting secondary loss of response in inflammatory bowel diseases","volume":"14","author":"Grasmeier","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104098_bb0705","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/ecco-jcc\/jjab067","article-title":"Dose optimisation for loss of response to vedolizumab- pharmacokinetics and immune mechanisms","volume":"15","author":"Ungar","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0710","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/gutjnl-2017-315494","article-title":"Cell-centred meta-analysis reveals baseline predictors of anti-TNF\u03b1 non-response in biopsy and blood of patients with IBD","volume":"68","author":"Gaujoux","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104098_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627535","article-title":"Monocyte TREM-1 levels associate with anti-TNF responsiveness in IBD through autophagy and Fc\u03b3-receptor signaling pathways","volume":"12","author":"Prins","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0720","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2019.08.009","article-title":"Infliximab-tumor necrosis factor complexes elicit formation of anti-drug antibodies","volume":"157","author":"Bar-Yoseph","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0725","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68993-1","article-title":"Monocytes from infliximab-resistant patients with Crohn\u2019s disease exhibit a disordered cytokine profile","volume":"10","author":"Gaiani","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0730","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gutjnl-2017-315671","article-title":"Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn\u2019s disease","volume":"68","author":"Schmitt","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0735","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/ibd\/izaf015","article-title":"Mitochondrial dysfunction: unraveling the elusive biology behind anti-TNF response during ulcerative colitis","volume":"31","author":"Kioroglou","year":"2025","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0740","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.32149","article-title":"Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals","volume":"75","author":"Goikoetxea-Usandizaga","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104098_bb0745","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/JIR.S234710","article-title":"Human neutrophil elastase proteolytic activity in ulcerative colitis favors the loss of function of therapeutic monoclonal antibodies","volume":"13","author":"Curciarello","year":"2020","journal-title":"J Inflamm Res"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0750","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1513\/pats.200603-078AW","article-title":"Neutrophil elastase: mediator of extracellular matrix destruction and accumulation","volume":"3","author":"Chua","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0755","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3109\/00365521.2012.677954","article-title":"Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-\u03b1 therapy in pediatric inflammatory bowel disease","volume":"47","author":"M\u00e4kitalo","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0760","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jgh.15764","article-title":"Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-\u03b1 treatment resistance in inflammatory bowel disease","volume":"37","author":"Yau","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0765","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33331-8","article-title":"Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy","volume":"13","author":"Pavlidis","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0770","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-019-0322-z","article-title":"Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2026.104098_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116473","article-title":"Pathogenic Th17 cells orchestrate mucosal inflammation and drive secondary loss of response to infliximab in inflammatory bowel disease: clinical and mechanistic evidence","volume":"176","author":"Li","year":"2026","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104098_bb0780","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104098_bb0785","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104098_bb0790","doi-asserted-by":"crossref","first-page":"1608202","DOI":"10.3389\/falgy.2025.1608202","article-title":"Eosinophils in inflammatory bowel disease pathogenesis: an ROS-centric view","volume":"6","author":"Tomii","year":"2025","journal-title":"Front Allergy"},{"issue":"4","key":"10.1016\/j.autrev.2026.104098_bb0795","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/mi.2014.123","article-title":"IL-1\u03b2 in eosinophil-mediated small intestinal homeostasis and IgA production","volume":"8","author":"Jung","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0800","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jpn3.12076","article-title":"Role of peripheral and tissue eosinophils and eosinophil cationic protein in pediatric inflammatory bowel disease","volume":"78","author":"Kim","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0805","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ibd\/izz251","article-title":"Mucosal eosinophilia is an independent predictor of vedolizumab efficacy in inflammatory bowel diseases","volume":"26","author":"Kim","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.autrev.2026.104098_bb0810","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000605","article-title":"Fecal biomarkers of neutrophil and eosinophil origin reflect the response to biological therapy and corticosteroids in patients with inflammatory bowel disease","volume":"14","author":"Ling Lundstr\u00f6m","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104098_bb0815","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apt.15745","article-title":"Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn\u2019s disease patients with prior failure to anti-TNF treatment","volume":"52","author":"Biemans","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2026.104098_bb0820","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-981-16-8387-9_8","article-title":"Coordination of mucosal immunity by innate lymphoid cells","volume":"1365","author":"Zhou","year":"2022","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104098_bb0825","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.mucimm.2025.11.013","article-title":"ILC3s mediate intestinal immune-epithelial interactions via TGF-\u03b21 activation","volume":"19","author":"Coman","year":"2026","journal-title":"Mucosal Immunol"},{"issue":"6178","key":"10.1016\/j.autrev.2026.104098_bb0830","doi-asserted-by":"crossref","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0835","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.immuni.2025.05.016","article-title":"ILC3s sense gut microbiota through STING to initiate immune tolerance","volume":"58","author":"Zhou","year":"2025","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.autrev.2026.104098_bb0840","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104098_bb0845","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104098_bb0850","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6263","key":"10.1016\/j.autrev.2026.104098_bb0855","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:42:15Z","timestamp":1785166935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":171,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1568997226001126"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104098","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104098"}}